Stay updated on Nivolumab After Salvage Resection in Head and Neck Cancer Clinical Trial
Sign up to get notified when there's something new on the Nivolumab After Salvage Resection in Head and Neck Cancer Clinical Trial page.

Latest updates to the Nivolumab After Salvage Resection in Head and Neck Cancer Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoChange DetectedThe revision tag on the page updated from v3.6.2 to v3.6.3, signaling a minor maintenance release. This update does not modify the study details, eligibility criteria, or results on the page.SummaryDifference0.1%

- Check18 days agoChange DetectedAdded Revision: v3.6.2 and removed Revision: v3.6.0 to update the page's revision history.SummaryDifference0.1%

- Check32 days agoChange DetectedEnrollment status now indicates that the study is not recruiting participants, signaling that enrollment has closed. New help and navigation sections were added (How to Read a Study Record, Common Questions, How to Join a Study), and there are minor formatting/version updates (Intervention/Treatment formatting and Revision: v3.6.0).SummaryDifference0.5%

- Check40 days agoChange DetectedThe revision label has been updated from v3.5.4 to v3.5.5, indicating a new version of the page. This reflects a small update or patch to the page's documentation/versioning.SummaryDifference0.1%

- Check61 days agoChange DetectedThe page's revision tag was updated from v3.5.3 to v3.5.4, indicating a minor maintenance/version update to the page.SummaryDifference0.1%

- Check68 days agoChange DetectedThe study record now shows Completed and Results Posted, with new timing details and the addition of outcome measures for adverse events and disease-free survival. Old status fields and timepoint labels such as Active, not recruiting and 1 year have been removed to reflect the current record.SummaryDifference2%

Stay in the know with updates to Nivolumab After Salvage Resection in Head and Neck Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab After Salvage Resection in Head and Neck Cancer Clinical Trial page.